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Figure 1. Histological analysis stained with (A) Saf-O and (B–D) Alcian Blue: (A)
4 w growth; preconditioned (24 h) defect:cells, (B) 6 w growth; fresh defect:cells,
(C) 4 wk growth; fresh defect:2 wk CTA, and (D) 6 w growth; fresh defect:24 wk
CTA.)
out scaffold or foreign material. Good integration occurred with our
CTA. More mature CTA were more successful at ﬁlling the defect
and showed a uniform PG rich matrix. Biomechanical tests are un-
derway to assess the mechanical integrity of the interface. These
CTAs presents a new simplistic approach to cartilage repair and
with additional inﬂuences such as force and specialized growth
conditions these CTA may prove to yield a clinically relevant repair
platform.
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M.B. Bennink, F.A. van de Loo, W.B. van den Berg, P.M. van der
Kraan
Experimental Rheumatology and Advanced Therapeutics,
Nijmegen Ctr. for Molecular Life Sci., Univ. Med. Ctr. Nijmegen,
Nijmegen, Netherlands
Purpose: Articular cartilage shows poor intrinsic repair, leading
to progressive joint damage. Therapies like marrow stimulation
or tissue engineering of cartilage depend on the chondrogenic
differentiation of progenitor cells. However, this chondrogenesis
needs to take place in a diseased joint with an altered environment.
In this environment inﬂammatory mediators will be present in
elevated levels and these will activate inﬂammatory pathways
in differentiating chondrocyte precursors. We examined the role
of two inﬂammatory pathways in chondrocyte differentiation, the
NF-kB and SOCS-3 pathway as possible therapeutic targets to
optimize cartilage regeneration.
Methods: Human mesenchymal stem cells (hMSC) (Lonza) were
differentiated into the chondrogenic lineage. Cells were pelleted
in serum free chondrogenic medium supplemented with TGF-
beta and BMP-2. Interleukin-1 (IL-1) and osteoarthritic synovium
derived conditioned medium, both a model for inﬂammatory stim-
ulation, were added to hMSC undergoing chondrogenic differenti-
ation.
Two downstream pathways known to be induced by catabolic
factors such as IL-1 were examined: the NF-kB and the SOCS-3
pathway. To study the speciﬁc role of the NF-kB pathway cells were
lentivirally transfected with P65 siRNA hairpin to block P65 expres-
sion. Activation of the SOCS-3 pathway was mimicked by lentiviral
overexpression of SOCS-3. Chondrogenesis was examined by
determining mRNA levels of chondrogenic markers COL2A1 (col-
lagen type II) and ACAN (aggrecan). Proteoglycan deposition was
analyzed by safranin O staining of histological sections.
Results: Chondrogenic differentiation, as measured by expres-
sion of type II collagen and aggrecan and safranin O proteo-
glycan staining, was induced in the hMSC already strongly at
two weeks under the described anabolic conditions. IL-1 as well
as osteoarthritis synovium-conditioned medium inhibited chondro-
genesis of hMSC. Conditioned medium induced SOCS-3 mRNA
strongly in the hMSC undergoing chondrogenesis. IL-1 also in-
duced SOCS-3 mRNA, albeit at a lower level. Lentiviral over-
expression of SOCS-3 lead to total inhibition of chondrogenesis
already in the condition without catabolic factors. In addition, block-
ing the NF-kB pathway P65 siRNA resulted in complete inhibition
of chondrogenesis, even under anabolic conditions. Indicating that
NF-kB signaling is required for normal chondrogenesis
Conclusions: Our study shows that the NF-kB pathway appears
to be indispensable for chondrogenesis. This demonstrates NF-
kB is unsuitable as a target to stimulate chondrogenesis in an
inﬂammatory milieu. SOCS-3 was induced by catabolic factors
and overexpression of SOCS-3 potently inhibited chondrogenesis.
SOCS-3 is therefore a potential candidate target to modulate
the inhibiting effect of catabolic factors on chondrogenesis and
blocking SOCS-3 in diseased joints could improve cartilage repair
through de-repression of chondrogenesis.
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Purpose: The transcription factor Sox9 plays an important role
in the regulation of skeletal growth and cartilage formation. De
novo mutations in the coding region of Sox9 cause campomelic
dysplasia, an autosomal dominant, frequently lethal disease.
Moreover, Sox9 is known to control the initial steps of chondrogenic
differentiation in mesenchymal stem cells (MSC). Recent studies
have emphasized the role of cell cycle regulators like p21 in the
coordination of chondrocyte proliferation and differentiation. But
otherwise, less is known about the function of the chondrocyte
transcription factor Sox9 in cell cycle progression and cellular
distribution in the different cell cycle phases. There is evidence
that Sox9 might alter cell cycle progression to facilitate its pro-
differentiating function in a rat chondrocytic cell line.
Methods: We have employed RNA interference (RNAi) to study
the effects of Sox9 gene knockdown in vitro, in undifferentiated
multipotent rMSC (rat mesenchymal stem cells derived from bone
marrow). Cells were transduced with a retroviral vector contain-
ing a Sox9-speciﬁc shRNA. After selection with the appropriate
antibiotics, the knockdown level of Sox9 was determined by gene
expression analysis with quantitative PCR and the protein amount
by western blotting. Subsequently, a real-time PCR based cell
cycle proﬁler pathway array was performed to detect alterations
in the expression of 84 different cell cycle speciﬁc genes after an
inhibiting Sox9 expression in rMSC. For further analysis of the cell
cycle distribution, cells were ﬁxed with 70% ethanol and stained
with propidium iodide to investigate cell populations for G0/G1, S
and M phases by ﬂow cytometric measurement.
Results: A reproducible knockdown, on average between 50%
and 90%, was observed in rMSC on the mRNA and the protein
level. Cells expressing less Sox9 caused by the Sox9-shRNA,
showed a clear decrease in proliferation. Hence, there is evidence
for an effect of Sox9 on cell cycle progression. The Sox9 gene
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knockdown seems to impair cell growth and alters cell cycle distri-
bution. An experimental set up, using a RT-PCR based cell cycle
pathway array showed a reproducible up regulation of LOC688900
in rMSC, which encodes Schlafen-1, a protein known as an inducer
of cell cycle arrest in T-lymphocytes and murine ﬁbroblasts.
Conclusions: Based on these knockdown studies we hold a
promising tool for further in vitro analyses and differentiation stud-
ies in MSC. According to the present data, we conclude an involve-
ment of Sox9 in cell cycle progression and thus cell proliferation,




PROLONG THE DELIVERY OF CARTILAGE-INDUCING
GROWTH FACTORS: A PROMISING SYSTEM FOR
STIMULATING SELF-REPAIR OF DAMAGED ARTICULAR
SURFACES
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M.C. Farach-Carson2, C.B. Kirn-Safran1
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Purpose: During the early stages of osteoarthritis (OA), growth
factors with high afﬁnity for both cartilage and bone extracellular
matrix are released and become involved in the repair of lesions.
Recently, bone morphogenetic protein 2 (BMP-2), a growth factor
with heparan sulfate (HS) binding capability, demonstrated an-
abolic cartilage activity when locally administered in the joint space
of OA animal models. Because clearance of small compounds
from the synovial ﬂuid into the lymphatic system is efﬁcient, the
residence time of highly diffusible, unbound cartilage-stimulating
factors such as BMP-2 is extremely limited, and the release of
these factors often is unable to counteract the damaging effects
of proteinases and inﬂammatory cytokines. For this reason, our
goal is to develop a novel delivery system for slow release of
chondrogenic factors to induce local repair of damaged articular
cartilage surfaces and slow the progression of OA.
Methods: The repair potential of perlecan-based bioactive com-
plexes was tested using an in vitro stem cell differentiation system
and an in vivo intra-articular injection method in mice displaying
early signs of knee OA (papain-induced OA model).
Results: We show that a HS-bearing fragment of perlecan cou-
pled to hyaluronan (HA) microparticles prolongs delivery of BMP-2
and supports chondrocyte differentiation in vitro. In addition, pre-
liminary results indicate that proteoglycan depletion is attenuated
when BMP2 is administered in combination with these HS per-
lecan fragment-HA biomatrices.
Conclusions: Perlecan-based growth factor delivering systems
are efﬁcient at inducing chondrogenic differentiation in vitro and
constitute potential novel therapeutic tools for inducing cartilage
self-repair mechanisms in vivo. Ultimately, this new therapeu-
tic strategy is expected to beneﬁt patients by locally inducing
self-regeneration of damaged articular surfaces and preventing
development of irreversible OA symptoms.
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Purpose: Articular cartilage damage has a very low spontaneous
healing capacity. A cell-based therapy with an appropriate source
would offer the opportunity to promote articular cartilage repair.
Stem cells are characterized by their multipotentiality and capacity
for self-renewal and may represent units of active regeneration for
tissues damaged as a result of trauma or disease. Synovium can
be easily harvested. Many attempts have been made to develop a
cell-surface antigen proﬁle for the better puriﬁcation and identiﬁca-
tion of MSCs. However, the identiﬁcation of MSC subpopulations
in culture has been hampered by the lack of appropriate mark-
ers. Thus there is a clear need to develop strategies leading to
the identiﬁcation of potential MSC (sub)population markers. The
objective of this study was to characterize the mixed synovial cell
population (MSCP) and puriﬁed type-B synovial ﬁbroblasts (SFB)
derived from pig synovium by using various known cell-surface
markers and evaluate their chondrogenic differentiation potentials
using a chondrogenic media containing growth factor TGF-β1.
Methods: Cells were isolated from synovium of porcine knee
joints. SF-Bs were negatively isolated by magnetic bead separation
using Dynal CD14.
Flow cytometry analysis was performed with MSCP or SFB
cells. Direct conjugated Ab used for ﬂow cytometry included
anti-CD44-ﬂuorescein isothhiocyanate (FITC), CD90-FITC, CD45-
FITC, CD34-FITC, CD11b-phycoerythrin (PE). Unconjungated Ab
is anti-CD14 and appropriate secondary Ab. Analysis was per-
formed with FlowJo software. 0.5×106 cells were centrifuged at
1000 rpm for 10 minutes. With the supplement of TGF-β1, pellets
were cultured in deﬁned differentiation medium, at 37°C; 5% CO2.
Pellets were harvested for biochemical and histological analyses,
and digested (2 hr at 60°C) in 300 μl papain (125 μg/ml papain, 5
mM cysteine). DNA content was measured via ﬂuorometric assay
using Hoechst 3325. GAG concentration was measured by the
dimethyl-methylene blue dye assay.
Pellets were ﬁxed in 1:1 methanol:acetone solution at 4°C, em-
bedded in parafﬁn, sectioned at 5 μm, and stained with Weigert’s
hemotoxylin and Safranin-O/Fast Green for sulfated GAGs and
immunostained for type II collagen.
Relative mRNA levels of collagenI, II and Aggrecan were deter-
mined by qPCR.
Statistics were performed using one-way ANOVA for at least n=4
where p<0.05 was considered signiﬁcant.
Results: To characterize the mixed synovial cell population and
puriﬁed type-B synovial ﬁbroblasts ﬂow cytometry was performed.
The positive markers in MSCP were CD14, CD44, CD90, cadherin-
11. After puriﬁcation, the macrophage marker CD14 disappeared
Figure 1. Surface molecule proﬁle of the mixed synovial cell population (MSCP)
and puriﬁed type-B synovial ﬁbroblasts (SFB) using ﬂow cytometry.
